To confirm the clinical relevance of ZNF638 in GBM, we demonstrated that ZNF638 was uniquely enriched in GBM tissue relative to matched normal cerebral cortex via IHC and Western blot (Figure 4, A–C, and Supplemental Tables 1 and 2). Here, ZNF638 is linked to glioblastoma.